Secondary Logo

Journal Logo

Articles by Lars Lind

A18355 Age- sex- and ethnicity-specific prediction of cardiovascular outcomes by in-office and out-of-the-office blood pressure: a subject-level meta-analysis of 17,383 adults enrolled in 17 population studies

Li, Yan; Thijs, Lutgarde; Asayama, Kei; More

Journal of Hypertension. 36:e310-e311, October 2018.

A18029 Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New ACC/AHA Classification of Hypertension

Staessen, Jan; Cheng, Yi-Bang; Thijs, Lutgarde; More

Journal of Hypertension. 36:e345, October 2018.

Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations

Fan, Hong-Qi; Li, Yan; Thijs, Lutgarde; More

Journal of Hypertension. 28(10):2036-2045, October 2010.

Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals

Hansen, Tine W; Kikuya, Masahiro; Thijs, Lutgarde; More

Journal of Hypertension. 25(8):1554-1564, August 2007.

B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

Hallberg, Pär; Lind, Lars; Michaëlsson, Karl; More

Journal of Hypertension. 21(3):621-624, March 2003.

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial

Hallberg, Pär; Karlsson, Julia; Kurland, Lisa; More

Journal of Hypertension. 20(10):2089-2093, October 2002.

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

Kurland, Lisa; Melhus, Håkan; Karlsson, Julia; More

Journal of Hypertension. 20(4):657-663, April 2002.

Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients

Kurland, Lisa; Melhus, Håkan; Karlsson, Julia; More

Journal of Hypertension. 19(10):1783-1787, October 2001.

Show: